Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Good
|
New words:
AAO, Academy, ADA, analyst, anatomic, appeal, argument, bevacizumab, Blueprint, branch, Brolucizumab, BRVO, bulk, burden, capped, choroidal, Circuit, Clarity, CMS, CNV, cohort, concomitant, Concurrently, constrain, correlated, CRVO, delisting, dry, drying, entirety, EOP, epithelial, examined, exudative, feedback, figure, flattening, fluid, glaucoma, goal, grace, group, heard, hearing, height, HHS, hosted, imprisonment, infrequent, interval, intraretinal, Intriguingly, Israel, Judge, lend, licensure, light, low, mandate, maximal, mCNV, micron, multifactorial, myopia, myopic, neurodegenerative, notified, NPDR, objective, objectively, occasion, oral, Panel, passed, pathologic, PED, penny, pigment, placebo, pocket, preliminary, presence, President, proliferative, prolonged, proof, proportion, randomized, ranibizumab, Salzberg, sBLA, Sciabacucchi, secondary, SEM, sequence, sequencing, sham, shelf, stability, stayed, stringent, subretinal, Subspecialty, transient, transparency, triplet, Trump, twofold, UK, unclear, unconstitutional, underscore, undertaken, vast, webcast, website, window, worsening, writing
Removed:
arranged, bioactivity, Certification, designing, fall, fully, highest, notably, persuade, reversing, sustained
Filing tables
Filing exhibits
Related press release
Associated KOD transcripts
KOD similar filings
Filing view
External links